Medizinische Universität Graz - Research portal
Ribitsch Anja |
** = Publications listed in SCI/SSCI/Pubmed
2015
Full paper/article (Journal)
** Hermanns, N; Lilly, LC; Mader, JK; Aberer, F; Ribitsch, A; Kojzar, H; Warner, J; Pieber, TR
Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.
J Diabetes Sci Technol. 2015; 9(3):581-587
Doi: 10.1177/1932296815570709
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Treiber, G; Prietl, B; Fröhlich-Reiterer, E; Lechner, E; Ribitsch, A; Fritsch, M; Rami-Merhar, B; Steigleder-Schweiger, C; Graninger, W; Borkenstein, M; Pieber, TR
Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.
Clin Immunol. 2015; 161(2):217-224
Doi: 10.1016/j.clim.2015.08.002
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Mader, JK; Haas, W; Ribitsch, A; Samonigg, J; Höller, V; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J
Langzeit Follow-up diner Kohorte von Patienten mit diabetischem Fußsyndrom in der Steiermark.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S134-S134.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Ribitsch, A; Haas, W; Mader, JK; Samonigg, J; Horvath, K; Köhler, G;
Sourij, H; Pieber, TR; Plank, J
Long-term follow-up of a cohort with a history of diabetic foot ulcer
in Austria.
Diabetologia. 2015; 58(Suppl 1):S512-S512.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN.
[Poster]
Web of Science
** Treiber, G; Prietl, B; Frohlich-Reiterer, E; Ribitsch, A; Lechner, E; Graninger, W; Pieber, T
Defects in suppressive capacity of regulatory T cells differ in children and adults with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2015; 127: S146-S146.
[Oral Communication]
Web of Science
2014
Abstract (Journal)
** Mader, JK; Ribitsch, A; Horvath, K; Kump, P; Lipp, RW; Pieber, TR; Treiber, G
Medical treatment of adult nesidioblastosis - a case report.
Wiener Klinische Wochenschrift. 2014; 126(Suppl3):S155-S156.-14th International workshop on multiple endocrine neoplasia and other rare endocrine tumors (World MEN); SEP 25-27, 2014; Vienna, AUSTRIA.
[Poster]
Web of Science
** Mader, JK; Ribitsch, A; Sourij, H; Horvath, K; Pieber, TR; Treiber, G
Pasireotide as Treatment option for recurrent Hypoglycemia in adult Nesidioblastosis
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):565-566.-ÖGIM; SEP 25-27, 2014; Salzburg.
[Poster]
Web of Science
** Ribitsch, A; Kienreich, T; Mader, JK; Horvath, K; Pieber, TR; Treiber, G
Applications of Insulin Pumping Treatment and clinical Characteristics of Adult-Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2014; 126: S178-S179.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV ; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Ribitsch, A; Mader, JK; Köhler, G; von Lewinski, D; Pieber, TR; Treiber, G
Gute Genesung nach Diabetes Typ 1 Manifestation mit schwerer Ketoazidose, Insult, Rhabdomyolyse, akutem Nierenversagen und septischem Schock.
Wiener Klinische Wochenschrift. 2014; 126(S04):S178-S178.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Treiber, G; Prietl, B; Frohlich-Reiterer, E; Holler, E; Ribitsch, A; Fritsch, M; Rami-Merhar, B; Steigleder-Schweiger, C; Borkenstein, M; Pieber, TR
The Suppression Capacity of regulatory T-Cells improves itselves through Chloecalciferolgabe for young Patients after Diabetes Typ 1 New Manifestation - Says a random control Study
WIEN KLIN WOCHENSCHR. 2014; 126: S173-S174.
[Oral Communication]
Web of Science
** Treiber, G; Prietl, B; Fröhlich-Reiterer, E; Höller, E; Ribitsch, A; Fritsch, M; Rami-Merhar, B; Steigleder-Schweiger, C; Borkenstein, M; Pieber, TR
Cholecalciferol increases suppressor function in regulatory CD4+CD25+Foxp3+ T-cells from patients with new onset type 1 diabetes: a randomised controlled trial.
Diabetologia. 2014; 57(Supp.1):S104-S104.-50th Annual Meeting of the European Diabetes Association (EASD); SEP 15-19, 2014; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
** Treiber, G; Ribitsch, A; Frohlich-Reiterer, E; Prietl, B; Fritsch, M; Rami-Merhar, B; Steigleder-Schweiger, C; Borkenstein, M; Pieber, TR
Assessment of Beta Cells Residual Function for Patients with Diabetes Type 1-Applications of stimulator C-Peptid (90 Minutes) as well as Harn C- Peptid during the MMTT
WIEN KLIN WOCHENSCHR. 2014; 126: S174-S174.
[Poster]
Web of Science
2012
Abstract (Journal)
** Ribitsch, A; Tauschmann, M; Horki, V; Mader, J; Semlitsch, B; Horvath, K; Pieber, T; Bock, G
Possible effects of Immunoglobulin A Deficiency in the management of Type 1 Diabetes Mellitus in Pregnancy-2 Case Reports
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):569-569.
[Poster]
Web of Science
2011
Abstract (Journal)
** Ribitsch, A; Haas, W; Kohler, G; Valentin, T; Mader, J; Horvath, K; Pieber, TR; Bock, G
Spectrum of germs in infected wounds in neuropathic diabetic foot performance in the outpatient clinic of a tertiary center
WIEN KLIN WOCHENSCHR. 2011; 123: S13-S13.-ÖDG; NOV 17-19, 2011; Salzburg, Austria.
[Poster]
Web of Science